Nifty
:
22475.85
Sensex
:
73878.15
-172.35 (-0.76%)
-732.96 (-0.98%)
Nifty
Sensex
:
:
22475.85
73878.15
-172.35 (-0.76%)
-732.96 (-0.98%)

Vanta Bioscience Ltd.

Miscellaneous

Rating :
45/99

BSE: 540729 | NSE: Not Listed

NSE BSE
75.20
03-May-2024
  • Open
  • High
  • Low
  • Previous Close
  •  71.66
  •  75.24
  •  71.66
  •  71.66
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  7
  •  4.48
  •  101.64
  •  37.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 47.47
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 104.53
  • N/A
  • 2.71

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.36%
  • 0.94%
  • 25.97%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.73%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 125.07
  • 182.35

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 3.12
  • 2.72

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 15.05
  • 10.06

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Net Sales
-
6.28
9.69
9.82
13.75
12.08
Net Sales Growth
-
-35.19%
-1.32%
-28.58%
13.82%
 
Cost Of Goods Sold
-
0.94
0.70
0.82
1.18
1.32
Gross Profit
-
5.33
8.99
9.00
12.57
10.76
GP Margin
-
84.87%
92.78%
91.65%
91.42%
89.07%
Total Expenditure
-
8.67
6.22
5.87
9.38
8.81
Power & Fuel Cost
-
0.75
0.55
0.54
1.04
0.98
% Of Sales
-
11.94%
5.68%
5.50%
7.56%
8.11%
Employee Cost
-
3.46
2.67
2.51
3.93
2.90
% Of Sales
-
55.10%
27.55%
25.56%
28.58%
24.01%
Manufacturing Exp.
-
0.10
0.20
0.15
0.25
0.20
% Of Sales
-
1.59%
2.06%
1.53%
1.82%
1.66%
General & Admin Exp.
-
2.93
1.57
1.32
2.75
2.56
% Of Sales
-
46.66%
16.20%
13.44%
20.0%
21.19%
Selling & Distn. Exp.
-
0.49
0.54
0.48
0.23
0.40
% Of Sales
-
7.80%
5.57%
4.89%
1.67%
3.31%
Miscellaneous Exp.
-
0.00
0.00
0.05
0.00
0.45
% Of Sales
-
0%
0%
0.51%
0%
3.73%
EBITDA
-
-2.39
3.47
3.95
4.37
3.27
EBITDA Margin
-
-38.06%
35.81%
40.22%
31.78%
27.07%
Other Income
-
0.69
0.42
0.03
0.11
0.23
Interest
-
5.89
2.35
2.14
1.95
1.69
Depreciation
-
2.67
1.32
1.25
1.19
0.71
PBT
-
-10.26
0.23
0.59
1.34
1.10
Tax
-
0.18
0.09
0.14
0.33
0.41
Tax Rate
-
-1.75%
39.13%
23.73%
24.63%
37.27%
PAT
-
-6.48
0.08
0.45
1.00
0.70
PAT before Minority Interest
-
-10.44
0.13
0.45
1.01
0.70
Minority Interest
-
3.96
-0.05
0.00
-0.01
0.00
PAT Margin
-
-103.18%
0.83%
4.58%
7.27%
5.79%
PAT Growth
-
-
-82.22%
-55.00%
42.86%
 
EPS
-
-10.29
0.13
0.71
1.59
1.11

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
17.51
24.01
23.92
23.47
22.25
Share Capital
6.31
6.31
6.31
6.31
6.31
Total Reserves
11.20
17.70
17.61
17.16
15.94
Non-Current Liabilities
48.03
37.78
28.56
14.24
12.57
Secured Loans
35.18
28.96
22.84
13.15
12.17
Unsecured Loans
11.88
8.03
5.00
0.50
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
Current Liabilities
17.75
14.32
14.89
10.03
3.32
Trade Payables
4.22
2.46
0.47
0.49
0.46
Other Current Liabilities
9.79
8.56
10.16
7.42
2.62
Short Term Borrowings
3.73
3.22
4.15
1.88
0.00
Short Term Provisions
0.00
0.08
0.11
0.24
0.24
Total Liabilities
84.70
81.45
69.68
48.73
39.12
Net Block
57.22
36.12
29.39
20.76
17.90
Gross Block
64.37
41.16
33.11
23.23
19.18
Accumulated Depreciation
7.14
5.04
3.72
2.47
1.28
Non Current Assets
69.47
66.91
49.69
28.73
21.95
Capital Work in Progress
10.60
28.47
19.34
7.00
3.70
Non Current Investment
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
1.64
2.32
0.97
0.97
0.35
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
Current Assets
15.24
14.54
19.99
20.00
17.17
Current Investments
0.00
0.00
0.00
0.00
1.95
Inventories
7.16
7.24
9.76
14.01
9.24
Sundry Debtors
1.96
1.13
2.01
1.39
1.56
Cash & Bank
0.10
0.22
2.65
0.20
3.27
Other Current Assets
6.03
0.21
3.76
1.96
1.15
Short Term Loans & Adv.
5.86
5.74
1.79
2.45
0.22
Net Current Assets
-2.50
0.22
5.09
9.97
13.85
Total Assets
84.71
81.45
69.68
48.73
39.12

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
-0.63
5.28
6.97
2.34
-1.04
PBT
-10.26
0.23
0.59
1.34
1.10
Adjustment
8.56
3.66
3.37
3.14
2.40
Changes in Working Capital
1.08
1.39
3.01
-2.14
-4.54
Cash after chg. in Working capital
-0.63
5.28
6.97
2.34
-1.04
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.91
-17.18
-22.19
-7.35
-5.50
Net Fixed Assets
-2.53
-8.05
-9.88
-0.35
Net Investments
0.00
0.00
0.00
0.95
Others
-3.38
-9.13
-12.31
-7.95
Cash from Financing Activity
6.41
9.48
17.68
1.94
9.71
Net Cash Inflow / Outflow
-0.13
-2.43
2.46
-3.07
3.18
Opening Cash & Equivalents
0.22
2.65
0.20
3.27
0.09
Closing Cash & Equivalent
0.10
0.22
2.65
0.20
3.27

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
27.75
38.03
37.89
37.18
35.25
ROA
-12.57%
0.18%
0.76%
2.31%
1.78%
ROE
-50.31%
0.56%
1.89%
4.43%
3.14%
ROCE
-6.10%
4.00%
5.42%
8.62%
7.87%
Fixed Asset Turnover
0.12
0.26
0.36
0.67
0.65
Receivable days
89.94
59.32
61.93
38.14
45.95
Inventory Days
418.55
320.25
432.17
300.03
271.56
Payable days
1287.00
761.36
213.02
146.72
21.45
Cash Conversion Cycle
-778.52
-381.79
281.09
191.45
296.06
Total Debt/Equity
3.26
1.87
1.50
0.74
0.60
Interest Cover
-0.74
1.10
1.28
1.69
1.65

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018

News Update:


  • Vanta Bioscience bags order of Rs 1.2 crore from large Indian Multinational Company
    3rd Apr 2024, 09:29 AM

    The said studies will be carried out by the company from its state of art research facility at Gummidipundi, Chennai

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.